Clinical Trial: A Multi-Center Prospective Observational Study of JAQBO(R) Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07115706) titled 'A Multi-Center Prospective Observational Study of JAQBO(R) Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD' on Aug. 04.

Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of JAQBO(R) Tab. 20 mg(Zastaprazan citrate) patients who have been prescribed the investigational drug.

Study Start Date: Aug. 25

Study Type: OBSERVATIONAL

Condition: Erosive Gastroesophageal Reflux Disease

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jeil Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....